Omnia SanaPlant Comparison
Cowslip vs Pygeum
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Cowslip and Pygeum: they share 3 indicated uses (arthritis / joint pain, inflammation (general), skin irritation); 1 pharmacological action in common.
Evidence face-off — shared uses
| Condition | Cowslip | Pygeum | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 5/10 | Stronger for Pygeum |
| Inflammation (general) | 1/10 | 2/10 | Comparable evidence |
| Skin irritation | 1/10 | 5/10 | Stronger for Pygeum |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from sedative action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Supports lower urinary tract symptoms of benign prostatic hyperplasia (BPH) - a Cochrane meta-analysis of 18 RCTs (1562 men) found a moderate improvement in urinary symptoms and flow versus placebo, but the trials were small, short and methodologically weak, so the evidence remains uncertain
inferred from anti-inflammatory action
Supports lower urinary tract symptoms of benign prostatic hyperplasia (BPH) - a Cochrane meta-analysis of 18 RCTs (1562 men) found a moderate improvement in urinary symptoms and flow versus placebo, but the trials were small, short and methodologically weak, so the evidence remains uncertain
Supports lower urinary tract symptoms of benign prostatic hyperplasia (BPH) - a Cochrane meta-analysis of 18 RCTs (1562 men) found a moderate improvement in urinary symptoms and flow versus placebo, but the trials were small, short and methodologically weak, so the evidence remains uncertain
Safety, Cautions & Contraindications
Allergy risk: avoid if you’re allergic to cowslip/other Primula species (European Medicines Agency, 2012). Stomach sensitivity: use caution if you have gastritis or a stomach ulcer—cowslip can upset the stomach in some people (European Medicines Agency, 2012). Possible side effects (especially high dose): nausea, vomiting, diarrhea; allergic reactions can happen (European Medicines Agency, 2012). Pregnancy/breastfeeding: not recommended due to lack of good safety data (European Medicines Agency, 2012). Kids: many preparations are not recommended under 12 (and some root extracts under 4) unless a labeled product specifically allows it (European Medicines Agency, 2012).
Duke (2002) provides clinical evidence (score 2) for cowslip's expectorant and secretolytic activities, consistent with Commission E approval for bronchitis and cough with mucus. Dose: 0.5–1 g root or 1–2 g herb as tea three times daily. Saponins in the root are responsible for the expectorant action. Duke warns that the plant may cause hemolysis in large doses due to saponin content, and caution is warranted in individuals with aspirin sensitivity due to phenolic acid content (Duke, 2002).
Lower urinary tract / prostate symptoms must be medically assessed first to exclude prostate cancer. The evidence is mixed and rests on small, short, methodologically weak trials, so men with moderate or severe BPH should not rely on it instead of proven treatment.
Generally well tolerated, with mild gastrointestinal effects the most common report.
External Ids
Botanical Description
Low perennial herb (Primulaceae) forming a basal rosette of wrinkled, oval, softly hairy leaves that taper abruptly to a winged stalk. A single leafless flowering stem rises from the rosette bearing a one-sided umbel of small, fragrant, deep yellow, funnel-shaped flowers with orange spots at the throat, nodding on slender pedicels.[10]
Evergreen tree (Rosaceae), 10-30 m tall, with dark, fissured, red-brown bark (the source of the common name 'red stinkwood', from its unpleasant smell when cut). Leaves are glossy dark green, leathery, oblong with finely toothed margins. Small white, five-petalled flowers are borne in axillary racemes, followed by small reddish-brown, two-lobed fruit.
Habitat
Native across Europe and western Asia, growing in unimproved, species-rich grassland, meadows, pastures, open woodland and hedge banks on calcareous or well-drained soils.[10]
Native to montane forests of central and southern Africa (and Madagascar), growing at moderate to high altitude (roughly 900-3400 m). The species is CITES-listed and conservation-threatened owing to over-harvesting of bark for the pharmaceutical trade.
Harvesting
Flowers are picked in spring as they open; the root/rhizome is dug in autumn.
Bark is traditionally stripped from mature trees. Unsustainable stripping - especially removing bark all the way round the trunk - kills the tree and has driven population decline, so sustainable, partial and rotational bark harvesting or cultivated sources are recommended.
Traditional Uses
Cowslip has a long European folk tradition as an expectorant remedy for coughs and bronchial catarrh, and the flowers have traditionally been used as a mild sedative and for headache. Modern research on its saponin-rich root supports secretolytic (mucus-thinning) expectorant activity, and its flowers are rich in antioxidant phenolics.[1, 6]
Prunus africana bark has a traditional use in East and Central African ethnomedicine for urinary complaints, and its extract (marketed as Pygeum) became one of the most widely used European phytotherapy remedies for benign prostatic hyperplasia (BPH) symptoms in the 20th century. Clinical evidence for symptom benefit is moderate but drawn from small, methodologically weak trials.[11]
Preparations
The clinically studied commercial form, standardised for phytosterol content.
Dosage
Clinical trials have most often used around 100-200 mg/day of standardised lipophilic bark extract, divided into two doses. Educational reference only, not a prescription; any prostate or urinary symptom should be medically assessed first.
References
Drug Class Interactions
Not documented
Lookalikes Review
References & Sources
- Veldman, J., Bordewijk, E., Lloyd, A.R., Vlieger, A.M. and others (2023) 'Mechanistic Evidence of Andrographis paniculata, Pelargonium sidoides, Echinacea Species and a Combination of Hedera helix, Primula veris/elatior and Thymus vulgaris/zygis in the Treatment of Acute, Uncomplicated Respiratory Tract Infections: A Systematic Literature Review and Expert Interviews', Pharmaceuticals (Basel), 16(9), pp. 1206. doi:10.3390/ph16091206 Meta-analysis / review
https://doi.org/10.3390/ph16091206 - Baczek, K.B., Kosakowska, O., Przybyl, J.L., Pioro-Jabrucka, E. and others (2017) 'Phenolics in Primula veris L. and Primula elatior (L.) Hill Raw Materials', International Journal of Analytical Chemistry, 2017, pp. 2871579. doi:10.1155/2017/2871579 Preclinical
https://doi.org/10.1155/2017/2871579 - Prokofiev, A.B., Latypova, G.M., Bondarenko, T.A., Romanenko, E.B. and others (2023) 'Solid herbal extract of Primula veris L. improves morphofunctional condition of rats' myocardium in chronic alcohol intoxication', Journal of Traditional and Complementary Medicine, 13(3), pp. 306-314. doi:10.1016/j.jtcme.2023.02.006 Preclinical
https://doi.org/10.1016/j.jtcme.2023.02.006 - Tarapatskyy, M., Gumienna, A., Sowa, P., Kapusta, I. and Puchalski, C (2021) 'Bioactive Phenolic Compounds from Primula veris L.: Influence of the Extraction Conditions and Purification', Molecules, 26(4), pp. 997. doi:10.3390/molecules26040997 Preclinical
https://doi.org/10.3390/molecules26040997 - Trendafilova, A., Ivanova, V., Todorova, M., Aneva, I. and others (2025) 'Phytochemical Characterization and Anti-Biofilm Activity of Primula veris L. Roots', Molecules, 30(8), pp. 1702. doi:10.3390/molecules30081702 Preclinical
https://doi.org/10.3390/molecules30081702 - Colombo, P.S., Flamini, G., Rodondi, G., Giuliani, C. and others (2017) 'Phytochemistry of European Primula species', Phytochemistry, 143, pp. 132-144. doi:10.1016/j.phytochem.2017.07.005 Traditional / reference
https://doi.org/10.1016/j.phytochem.2017.07.005 - Latypova, G.M., Bondarenko, T.A., Katayev, V.A., Romanenko, E.B. and others (2019) 'Composition and cardioprotective effects of Primula veris L. solid herbal extract in experimental chronic heart failure', Phytomedicine, 54, pp. 17-26. doi:10.1016/j.phymed.2018.09.015 Preclinical
https://doi.org/10.1016/j.phymed.2018.09.015 - Brys, R. and Jacquemyn, H (2015) 'Disruption of the distylous syndrome in Primula veris', Annals of Botany, 115(1), pp. 27-39. doi:10.1093/aob/mcu211 Preclinical
https://doi.org/10.1093/aob/mcu211 - Muller, A., Ganzera, M. and Stuppner, H (2006) 'Analysis of phenolic glycosides and saponins in Primula elatior and Primula veris (primula root) by liquid chromatography, evaporative light scattering detection and mass spectrometry', Journal of Chromatography A, 1112(1-2), pp. 218-223. doi:10.1016/j.chroma.2005.10.067 Preclinical
https://doi.org/10.1016/j.chroma.2005.10.067 - Graikou, K., Damianakos, H., Ganos, C., Syklowska-Baranek, K. and others (2023) 'Comparative Phytochemical Analyses of Flowers from Primula veris subsp. veris Growing Wild and from Ex Situ Cultivation in Greece', Foods, 12(13), pp. 2623. doi:10.3390/foods12132623 Preclinical
https://doi.org/10.3390/foods12132623 - European Medicines Agency (2012) 'European Union herbal monograph on Primula veris L'. Traditional / reference
https://scholar.google.com/scholar?q=European%20Union%20herbal%20monograph%20on%20Primula%20veris%20L - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Wicke, L (2007) 'Primula veris in the treatment of upper respiratory infections', pp. 109--116. Traditional / reference
https://scholar.google.com/scholar?q=Primula%20veris%20in%20the%20treatment%20of%20upper%20respiratory%20infections - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
- Thompson, R.Q., Katz, D. and Sheehan, B (2019) 'Chemical comparison of Prunus africana bark and pygeum products marketed for prostate health', Journal of Pharmaceutical and Biomedical Analysis, 163, pp. 162-169. doi:10.1016/j.jpba.2018.10.004 Preclinical
https://doi.org/10.1016/j.jpba.2018.10.004 - Dvorkin, L. and Song, K.Y (2002) 'Herbs for benign prostatic hyperplasia', The Annals of Pharmacotherapy, 36(9), pp. 1443-1452. doi:10.1345/aph.1A228 Meta-analysis / review
https://doi.org/10.1345/aph.1A228 - Keehn, A. and Lowe, F.C (2015) 'Complementary and alternative medications for benign prostatic hyperplasia', The Canadian Journal of Urology, 22(Suppl 1), pp. 18-23. Meta-analysis / review
https://scholar.google.com/scholar?q=Complementary%20and%20alternative%20medications%20for%20benign%20prostatic%20hyperplasia - Kim, T.H., Lim, H.J., Kim, M.S. and Lee, M.S (2012) 'Dietary supplements for benign prostatic hyperplasia: an overview of systematic reviews', Maturitas, 73(3), pp. 180-185. doi:10.1016/j.maturitas.2012.07.007 Meta-analysis / review
https://doi.org/10.1016/j.maturitas.2012.07.007 - Cambronero, J., Osca-Garcia, J.M., Merino-Salas, S., Miguel, J.M. and others (2022) 'Effectiveness of treatment with Pygeum africanum in patients with lower urinary tract symptoms and benign prostatic hyperplasia: a cross-sectional study in the real-world clinical practice in Spain (The PROFIT Study)', Archivos Espanoles de Urologia, 75(3), pp. 219-227. Clinical study
https://scholar.google.com/scholar?q=Effectiveness%20of%20treatment%20with%20Pygeum%20africanum%20in%20patients%20with%20lower%20urinary%20tract%20symptoms%20and%20benign%20prostatic%20hyperplasia%3A%20a%20cross-sectional%20study%20in%20the%20real-world%20clinical%20practice%20in%20Spain%20%28The%20PROFIT%20Study%29 - Quiles, M.T., Arbos, M.A., Fraga, A., de Torres, I.M. and others (2010) 'Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH)', The Prostate, 70(10), pp. 1044-1053. doi:10.1002/pros.21138 Preclinical
https://doi.org/10.1002/pros.21138 - Salinas-Casado, J., Esteban-Fuertes, M., Carballido-Rodriguez, J. and Cozar-Olmo, J.M (2020) 'Review of the experience and evidence of Pygeum africanum in urological practice', Actas Urologicas Espanolas, 44(1), pp. 9-13. doi:10.1016/j.acuro.2019.08.002 Meta-analysis / review
https://doi.org/10.1016/j.acuro.2019.08.002 - Villar, A., Silva-Fuentes, F., Mula, A. and Zangara, A (2024) 'Anti-Inflammatory Potential of Prunus africana Bark Extract: An In Vitro Study of Cytokine Release by Lipopolysaccharide-Stimulated Human Peripheral Blood Mononuclear Cells', International Journal of Molecular Sciences, 25(15), pp. 8298. doi:10.3390/ijms25158298 Preclinical
https://doi.org/10.3390/ijms25158298 - Larre, S., Camparo, P., Comperat, E., Boulbes, D. and others (2012) 'Biological effect of human serum collected before and after oral intake of Pygeum africanum on various benign prostate cell cultures', Asian Journal of Andrology, 14(3), pp. 499-504. doi:10.1038/aja.2011.132 Preclinical
https://doi.org/10.1038/aja.2011.132 - Rubegeta, E., Makolo, F., Kamatou, G., Enslin, G. and others (2023) 'The African cherry: A review of the botany, traditional uses, phytochemistry, and biological activities of Prunus africana (Hook.f.) Kalkman', Journal of Ethnopharmacology, 305, pp. 116004. doi:10.1016/j.jep.2022.116004 Meta-analysis / review
https://doi.org/10.1016/j.jep.2022.116004 - Keehn, A. and Lowe, F.C (2015) 'Complementary and alternative medications for benign prostatic hyperplasia', The Canadian Journal of Urology. Randomized trial
https://scholar.google.com/scholar?q=Complementary%20and%20alternative%20medications%20for%20benign%20prostatic%20hyperplasia - Dedhia, R.C. and McVary, K.T (2008) 'Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia', The Journal of Urology, 179(6), pp. 2119--2125. doi:10.1016/j.juro.2008.01.094 Meta-analysis / review
https://doi.org/10.1016/j.juro.2008.01.094 - Wilt, T. and Ishani, A. and Mac Donald, R. and Rutks, I. and Stark, G (2002) 'Pygeum africanum for benign prostatic hyperplasia', Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD001044 Meta-analysis / review
https://doi.org/10.1002/14651858.CD001044
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.